Zobert 250 mg/250 mg Injection
By Zobert
Rx
1 Injection in a Vial

Composition
Cefoperazone(250mg) + Sulbactam(250mg)

Manufacturer - Viilbery Healthcare Pvt Ltd
Viilbery Healthcare Pvt. Ltd. Plot No. P- 64, Milap Nagar, M. I. D. C Residential Zone Near AIMS Hospital, Dombivili, East, Thane - 421 203, Maharashtra, India.

Expires on or after
June, 2026

liver
Limited information is currently available regarding the use of Zobert 250 mg/250 mg Injection in individuals with liver disease. It is important to consult with your doctor before using this medication to ensure it is safe for you. Your doctor will be able to provide personalized guidance based on your specific liver condition and overall health.

kidney
Limited information is available on using Zobert 250 mg/250 mg Injection in patients with kidney disease. Please consult your doctor for guidance.

alcohol
When using Zobert 250 mg/250 mg Injection, avoid alcohol as it can lead to unwanted effects such as flushing, increased heart rate, nausea, chest pain, thirst, and low blood pressure (Disulfiram reaction).

driving
It is better to consult your doctor. Refrain from driving if you have symptoms impairing focus and reaction time when using Zobert 250 mg/250 mg Injection.

pregnancy
Zobert 250 mg/250 mg Injection is generally safe during pregnancy, as animal studies show minimal negative effects on the developing baby. Limited human studies are available.

breastfeeding
Zobert 250 mg/250 mg Injection is safe to use while breastfeeding. Research shows the medication does not pass into breastmilk in significant amounts, posing no harm to the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | ANTI INFECTIVES |
| Action Class | - |
₹67.5
₹75
10% OFF
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024
